A research team co-led by scientists at the University of Arizona College of Medicine – Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease.

Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...

Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...

Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, announced that Michel Lussier ...

The condition of an eight-month-old Hong Kong infant who received a heart transplant from a donor in mainland China is stable ...

The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 billion in 2024 and an impressive US$56.94 billion ...

"Dumbbells are among the most effective and accessible tools for beginners to start strength training ," agrees personal ...

A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often ...

A prospective randomized study published in BMJ Innovations found that Heartbeat Health's virtual-first cardiology program, when implemented after hospital discharge, significantly reduced ...

The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...

The Shapiro administration and the new Pennsylvania attorney are still trying to get Delaware County's Crozer Health back under nonprofit ownership to preserve services and jobs.